They predicted that inhibition of NBL1 to release BMP proteins can enable their interaction with and inhibition of TGF-β signaling, therefore diminishing inflammation and fibrosis in kidney tissue and podocyte loss in DKD. The gene discussed is TGFB1; the disease is diabetic kidney disease.